| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.674 | 0.004 | 0.674 | GABA C receptor rho-3 antagonist | 0.415 0.055 CID_5488302 | ||
| 0.612 | 0.006 | 0.612 | Dyrk kinase inhibitor | 0.239 0.077 CID_5488285 0.225 0.085 CID_5488302 | ||
| 0.578 | 0.007 | 0.578 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.244 0.07 CID_5488285 0.216 0.083 CID_5488302 | ||
| 0.569 | 0.009 | 0.569 | Calcium channel L-type activator | 0.444 0.054 CID_5488285 0.443 0.055 CID_5488302 | ||
| 0.557 | 0.014 | 0.557 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.34 0.163 CID_5488302 | ||
| 0.509 | 0.006 | 0.509 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.292 0.07 CID_5488302 | ||
| 0.498 | 0.019 | 0.498 | MAP kinase kinase 6 inhibitor | 0.278 0.158 CID_5488302 | ||
| 0.437 | 0.014 | 0.437 | Calcium channel activator | 0.238 0.161 CID_5488285 0.302 0.089 CID_5488302 | ||
| 0.457 | 0.035 | 0.457 | 5 Hydroxytryptamine release stimulant | 0.333 0.061 CID_5488285 | ||
| 0.415 | 0.018 | 0.415 | Peroxidase inhibitor | 0.189 0.062 CID_5488302 | ||
| 0.397 | 0.004 | 0.397 | GABA C receptor rho-2 antagonist | 0.15 0.074 CID_5488302 | ||
| 0.367 | 0.013 | 0.367 | Tyrosine 3 hydroxylase inhibitor | 0.196 0.142 CID_5488302 | ||
| 0.371 | 0.021 | 0.371 | EphB2 antagonist | |||
| 0.352 | 0.007 | 0.352 | Cyclin-dependent kinase 5 inhibitor | 0.106 0.07 CID_5488302 | ||
| 0.293 | 0.007 | 0.293 | Death-associated protein kinase 2 inhibitor | 0.188 0.045 CID_5488302 | ||
| 0.299 | 0.016 | 0.299 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.389 | 0.118 | 0.616 | Caspase 9 stimulant | 0.616 0.034 CID_5488285 | CID_5488285 | |
| 0.274 | 0.004 | 0.274 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.142 0.017 CID_5488285 0.115 0.027 CID_5488302 | ||
| 0.279 | 0.014 | 0.279 | Cyclin-dependent kinase 2 inhibitor | |||
| 0.398 | 0.14 | 0.719 | Antiinflammatory | 0.719 0.027 CID_5488285 0.332 0.187 CID_5488302 | CID_5488285 | |
| 0.31 | 0.052 | 0.31 | Cardiotonic | |||
| 0.318 | 0.062 | 0.318 | Aldehyde oxidase inhibitor | |||
| 0.273 | 0.018 | 0.273 | MAO A inhibitor | |||
| 0.293 | 0.038 | 0.293 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.282 | 0.035 | 0.282 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.355 | 0.111 | 0.515 | 5 Hydroxytryptamine release inhibitor | 0.515 0.028 CID_5488285 | CID_5488285 | |
| 0.285 | 0.042 | 0.285 | Death-associated protein kinase 3 inhibitor | |||
| 0.287 | 0.047 | 0.514 | Cyclic AMP phosphodiesterase inhibitor | 0.514 0.006 CID_5488285 | CID_5488285 | |
| 0.236 | 0.005 | 0.236 | GABA C receptor rho-1 antagonist | |||
| 0.261 | 0.032 | 0.261 | I kappa B kinase epsilon inhibitor | |||
| 0.245 | 0.018 | 0.245 | 5 Hydroxytryptamine 3E antagonist | 0.169 0.14 CID_5488302 | ||
| 0.254 | 0.028 | 0.254 | MAP kinase kinase 3 inhibitor | |||
| 0.261 | 0.034 | 0.261 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.186 0.057 CID_5488302 | ||
| 0.281 | 0.065 | 0.366 | DNA damaging | 0.366 0.036 CID_5488285 | CID_5488285 | |
| 0.235 | 0.03 | 0.235 | Cyclin-dependent kinase inhibitor | |||
| 0.309 | 0.105 | 0.309 | Toll-Like receptor 7 agonist | |||
| 0.263 | 0.061 | 0.263 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.211 | 0.011 | 0.211 | GABA C receptor antagonist | 0.145 0.033 CID_5488302 | ||
| 0.305 | 0.108 | 0.305 | Toll-Like receptor agonist | 0.201 0.2 CID_5488285 | ||
| 0.208 | 0.012 | 0.208 | Antineoplastic alkaloid | 0.098 0.049 CID_5488285 | ||
| 0.194 | 0.005 | 0.194 | I kappa B kinase 1 inhibitor | 0.082 0.035 CID_5488302 | ||
| 0.241 | 0.066 | 0.241 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.251 | 0.078 | 0.251 | Aryl hydrocarbon receptor agonist | |||
| 0.237 | 0.066 | 0.237 | Interleukin antagonist | 0.205 0.081 CID_5488285 | ||
| 0.222 | 0.055 | 0.222 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.187 | 0.022 | 0.187 | MAP3K9 inhibitor | |||
| 0.292 | 0.128 | 0.611 | Histamine release inhibitor | 0.611 0.009 CID_5488285 0.426 0.062 CID_5488302 | CID_5488285 | |
| 0.173 | 0.009 | 0.173 | MAP-kinase-activated kinase inhibitor | 0.083 0.057 CID_5488302 | ||
| 0.227 | 0.065 | 0.227 | MAP kinase kinase 2 inhibitor | |||
| 0.217 | 0.057 | 0.217 | Focal adhesion kinase 2 inhibitor | |||
| 0.198 | 0.041 | 0.198 | MAO inhibitor | |||
| 0.22 | 0.066 | 0.22 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.224 | 0.071 | 0.224 | Antimitotic | 0.156 0.116 CID_5488285 0.143 0.128 CID_5488302 | ||
| 0.314 | 0.162 | 0.58 | Apoptosis agonist | 0.58 0.054 CID_5488285 | CID_5488285 | |
| 0.194 | 0.043 | 0.302 | NOS3 expression enhancer | 0.302 0.018 CID_5488285 | CID_5488285 | |
| 0.159 | 0.009 | 0.159 | MAP-kinase-activated kinase 2 inhibitor | 0.077 0.048 CID_5488302 | ||
| 0.166 | 0.017 | 0.166 | Porphobilinogen synthase inhibitor | 0.16 0.018 CID_5488302 | ||
| 0.189 | 0.041 | 0.189 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.193 | 0.045 | 0.193 | Vascular endothelial growth factor 3 antagonist | |||
| 0.187 | 0.043 | 0.187 | CDC-like kinase 1 inhibitor | |||
| 0.173 | 0.03 | 0.173 | Aurora-C kinase inhibitor | |||
| 0.206 | 0.063 | 0.206 | CDC-like kinase 2 inhibitor | |||
| 0.164 | 0.023 | 0.164 | Death-associated protein kinase 1 inhibitor | |||
| 0.162 | 0.027 | 0.162 | Interleukin 8 antagonist | |||
| 0.178 | 0.045 | 0.178 | Tubulin antagonist | |||
| 0.167 | 0.034 | 0.167 | Aurora-A kinase inhibitor | |||
| 0.205 | 0.073 | 0.205 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.146 0.124 CID_5488285 | ||
| 0.172 | 0.043 | 0.214 | NADPH oxidase inhibitor | 0.214 0.03 CID_5488285 | CID_5488285 | |
| 0.211 | 0.083 | 0.211 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.212 | 0.084 | 0.348 | RNA-directed DNA polymerase inhibitor | 0.222 0.072 CID_5488285 0.348 0.024 CID_5488302 | CID_5488302 | |
| 0.154 | 0.029 | 0.231 | Photosensitizer | 0.231 0.008 CID_5488285 | CID_5488285 | |
| 0.2 | 0.076 | 0.262 | Neurotrophic factor enhancer | 0.262 0.032 CID_5488285 | CID_5488285 | |
| 0.163 | 0.039 | 0.182 | Interleukin 4 antagonist | 0.182 0.029 CID_5488285 | CID_5488285 | |
| 0.164 | 0.041 | 0.164 | Aurora-B kinase inhibitor | |||
| 0.142 | 0.019 | 0.142 | MAP kinase 11 inhibitor | |||
| 0.173 | 0.051 | 0.173 | Activin receptor-like kinase 2 inhibitor | |||
| 0.172 | 0.05 | 0.172 | Toll-Like receptor 9 antagonist | |||
| 0.163 | 0.041 | 0.163 | MAP kinase kinase 4 inhibitor | |||
| 0.198 | 0.082 | 0.198 | Pyruvate kinase inhibitor | |||
| 0.179 | 0.066 | 0.179 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.13 | 0.018 | 0.13 | Interleukin 5 antagonist | 0.115 0.027 CID_5488285 | ||
| 0.19 | 0.081 | 0.19 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.136 | 0.028 | 0.136 | Protein kinase C delta inhibitor | |||
| 0.211 | 0.107 | 0.371 | DNA synthesis inhibitor | 0.371 0.026 CID_5488285 | CID_5488285 | |
| 0.11 | 0.005 | 0.11 | Cyclin D1 inhibitor | |||
| 0.178 | 0.074 | 0.178 | LIM domain kinase 1 inhibitor | |||
| 0.189 | 0.086 | 0.189 | Clk dual-specificity kinase inhibitor | |||
| 0.197 | 0.094 | 0.249 | Nitric-oxide synthase stimulant | 0.249 0.033 CID_5488285 | CID_5488285 | |
| 0.129 | 0.028 | 0.129 | MAP kinase kinase 1 inhibitor | |||
| 0.161 | 0.064 | 0.161 | Protein kinase C nu inhibitor | |||
| 0.132 | 0.035 | 0.395 | Beta glucuronidase inhibitor | 0.395 0.004 CID_5488285 | CID_5488285 | |
| 0.132 | 0.035 | 0.132 | Protein kinase C mu inhibitor | |||
| 0.138 | 0.043 | 0.138 | Ferrochelatase inhibitor | |||
| 0.147 | 0.053 | 0.147 | MAP kinase kinase inhibitor | 0.114 0.08 CID_5488302 | ||
| 0.135 | 0.041 | 0.135 | Protein kinase C gamma inhibitor | |||
| 0.174 | 0.083 | 0.174 | CDC-like kinase 4 inhibitor | |||
| 0.156 | 0.066 | 0.157 | CF transmembrane conductance regulator agonist | 0.157 0.064 CID_5488285 | CID_5488285 | |
| 0.134 | 0.045 | 0.134 | GABA receptor agonist | |||
| 0.115 | 0.026 | 0.115 | Bromodomain-containing protein 2 inhibitor | |||
| 0.112 | 0.024 | 0.13 | Phosphodiesterase XI inhibitor | 0.13 0.016 CID_5488302 | CID_5488302 | |
| 0.112 | 0.024 | 0.13 | Phosphodiesterase 11A inhibitor | 0.13 0.016 CID_5488302 | CID_5488302 | |
| 0.133 | 0.048 | 0.133 | Alpha 2b adrenoreceptor antagonist | |||
| 0.16 | 0.077 | 0.16 | Arachidonic acid antagonist | |||
| 0.134 | 0.052 | 0.134 | Glycogen synthase kinase-3 inhibitor | |||
| 0.116 | 0.035 | 0.24 | Protein kinase C zeta inhibitor | 0.24 0.008 CID_5488302 | CID_5488302 | |
| 0.096 | 0.016 | 0.096 | MAP kinase kinase 7 inhibitor | |||
| 0.11 | 0.031 | 0.11 | I kappa B kinase inhibitor | |||
| 0.246 | 0.168 | 0.292 | 15-Lipoxygenase inhibitor | 0.292 0.137 CID_5488302 | CID_5488302 | |
| 0.12 | 0.043 | 0.12 | CDC-like kinase 3 inhibitor | |||
| 0.129 | 0.053 | 0.23 | DNA intercalator | 0.23 0.019 CID_5488285 0.172 0.035 CID_5488302 | CID_5488285 | |
| 0.084 | 0.007 | 0.084 | Glutamate (mGluR1a) antagonist | |||
| 0.082 | 0.006 | 0.082 | GABA B receptor antagonist | 0.047 0.023 CID_5488302 | ||
| 0.085 | 0.012 | 0.085 | Protein kinase C theta inhibitor | |||
| 0.098 | 0.025 | 0.098 | Cyclin E inhibitor | |||
| 0.105 | 0.033 | 0.105 | GABA A receptor agonist | |||
| 0.098 | 0.028 | 0.098 | Phosphodiesterase V inhibitor | 0.08 0.041 CID_5488302 | ||
| 0.087 | 0.017 | 0.087 | Dopamine D4 agonist | |||
| 0.089 | 0.019 | 0.089 | GABA A receptor antagonist | 0.076 0.023 CID_5488302 | ||
| 0.099 | 0.03 | 0.099 | D-Ala-D-Ala ligase inhibitor | |||
| 0.087 | 0.019 | 0.087 | GABA receptor antagonist | 0.085 0.02 CID_5488302 | ||
| 0.089 | 0.021 | 0.089 | MAP kinase 7 inhibitor | |||
| 0.168 | 0.101 | 0.385 | Psychostimulant | 0.385 0.025 CID_5488285 | CID_5488285 | |
| 0.071 | 0.004 | 0.071 | ATM kinase inhibitor | |||
| 0.089 | 0.022 | 0.089 | Cyclin E1 inhibitor | |||
| 0.115 | 0.048 | 0.179 | Carbonic anhydrase III inhibitor | 0.119 0.045 CID_5488285 0.179 0.02 CID_5488302 | CID_5488302 | |
| 0.139 | 0.073 | 0.139 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.218 | 0.153 | 0.657 | Transcription factor NF kappa B inhibitor | 0.657 0.025 CID_5488285 | CID_5488285 | |
| 0.114 | 0.049 | 0.114 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.152 | 0.088 | 0.152 | Tyrosine kinase inhibitor | |||
| 0.122 | 0.06 | 0.122 | Glycogen synthase kinase-3 beta inhibitor | |||
| 0.118 | 0.057 | 0.118 | 5 Hydroxytryptamine 3A agonist | |||
| 0.073 | 0.012 | 0.073 | Poly(ADP-ribose) polymerase inhibitor | |||
| 0.109 | 0.05 | 0.109 | Creatine kinase inhibitor | |||
| 0.082 | 0.023 | 0.082 | Protein kinase C eta inhibitor | 0.071 0.028 CID_5488285 | ||
| 0.09 | 0.032 | 0.09 | Phosphodiesterase 5A inhibitor | 0.078 0.042 CID_5488302 | ||
| 0.103 | 0.044 | 0.103 | Androgen antagonist | |||
| 0.143 | 0.085 | 0.143 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.075 | 0.017 | 0.075 | Lipocortins synthesis agonist | 0.06 0.036 CID_5488285 | ||
| 0.096 | 0.039 | 0.096 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.092 | 0.037 | 0.092 | Janus tyrosine kinase 3 inhibitor | |||
| 0.1 | 0.045 | 0.1 | Protein kinase A inhibitor | |||
| 0.13 | 0.075 | 0.156 | Interleukin 1 antagonist | 0.156 0.053 CID_5488285 | CID_5488285 | |
| 0.204 | 0.15 | 0.204 | Insulysin inhibitor | |||
| 0.066 | 0.012 | 0.066 | DNA-dependent protein kinase inhibitor | |||
| 0.142 | 0.089 | 0.284 | Hexokinase inhibitor | 0.284 0.012 CID_5488285 | CID_5488285 | |
| 0.141 | 0.089 | 0.141 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.069 | 0.017 | 0.069 | Topoisomerase II beta inhibitor | 0.052 0.03 CID_5488285 | ||
| 0.092 | 0.04 | 0.092 | CYP2A6 inhibitor | |||
| 0.109 | 0.058 | 0.109 | Alpha 2c adrenoreceptor antagonist | |||
| 0.084 | 0.033 | 0.084 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.089 | 0.039 | 0.089 | T cell inhibitor | 0.082 0.06 CID_5488285 | ||
| 0.137 | 0.087 | 0.137 | Ca2+-transporting ATPase inhibitor | 0.135 0.093 CID_5488285 | ||
| 0.185 | 0.135 | 0.359 | Superoxide dismutase inhibitor | 0.359 0.034 CID_5488302 | CID_5488302 | |
| 0.146 | 0.096 | 0.269 | Interleukin 6 antagonist | 0.269 0.019 CID_5488285 | CID_5488285 | |
| 0.084 | 0.035 | 0.084 | Phenylalanine 4-hydroxylase inhibitor | 0.071 0.046 CID_5488302 | ||
| 0.061 | 0.013 | 0.061 | Poly(ADP-ribose) polymerase 1 inhibitor | |||
| 0.056 | 0.008 | 0.056 | Cyclin E2 inhibitor | |||
| 0.107 | 0.06 | 0.107 | GABA C receptor agonist | |||
| 0.162 | 0.115 | 0.162 | Platelet aggregation inhibitor | |||
| 0.128 | 0.082 | 0.128 | Ribosomal protein S6 kinase inhibitor | |||
| 0.07 | 0.025 | 0.07 | Neuropeptide Y5 antagonist | |||
| 0.098 | 0.053 | 0.098 | CDK/cyclin complex inhibitor | |||
| 0.136 | 0.093 | 0.136 | MAP kinase 3 inhibitor | |||
| 0.085 | 0.042 | 0.085 | Rho-associated kinase inhibitor | |||
| 0.065 | 0.024 | 0.065 | 5 Hydroxytryptamine 7 agonist | |||
| 0.084 | 0.044 | 0.084 | MAP kinase 14 inhibitor | |||
| 0.261 | 0.221 | 0.261 | MAP kinase 1 inhibitor | |||
| 0.078 | 0.039 | 0.078 | Check point kinase 1 inhibitor | |||
| 0.197 | 0.158 | 0.197 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.078 | 0.039 | 0.078 | Cyclin B3 inhibitor | |||
| 0.093 | 0.055 | 0.183 | Triose-phosphate isomerase inhibitor | 0.122 0.031 CID_5488285 0.183 0.013 CID_5488302 | CID_5488302 | |
| 0.065 | 0.026 | 0.065 | Ryanodine receptor antagonist | |||
| 0.075 | 0.037 | 0.075 | Protein kinase C beta inhibitor | 0.066 0.056 CID_5488285 | ||
| 0.109 | 0.072 | 0.154 | Interleukin 1b antagonist | 0.154 0.037 CID_5488285 | CID_5488285 | |
| 0.072 | 0.036 | 0.072 | Aryl hydrocarbon receptor antagonist | |||
| 0.067 | 0.031 | 0.067 | Potassium channel (Ca-activated) blocker | |||
| 0.083 | 0.048 | 0.083 | MAP kinase 10 inhibitor | |||
| 0.054 | 0.02 | 0.054 | Benzodiazepine inverse agonist | |||
| 0.053 | 0.019 | 0.053 | CDK5/p25 inhibitor | |||
| 0.189 | 0.154 | 0.189 | Transcription factor STAT inhibitor | |||
| 0.107 | 0.073 | 0.107 | Activin receptor-like kinase 4 inhibitor | |||
| 0.09 | 0.057 | 0.09 | Pim-3 kinase inhibitor | |||
| 0.063 | 0.03 | 0.063 | Bromodomain-containing protein 4 inhibitor | |||
| 0.097 | 0.065 | 0.217 | UDP-glucose 4-epimerase inhibitor | 0.217 0.016 CID_5488285 | CID_5488285 | |
| 0.134 | 0.103 | 0.275 | Interferon gamma antagonist | 0.275 0.024 CID_5488285 | CID_5488285 | |
| 0.118 | 0.087 | 0.118 | Toll-Like receptor antagonist | |||
| 0.072 | 0.042 | 0.11 | Dopamine agonist | 0.11 0.023 CID_5488302 | CID_5488302 | |
| 0.203 | 0.173 | 0.325 | Vasodilator, peripheral | 0.325 0.085 CID_5488285 | CID_5488285 | |
| 0.034 | 0.005 | 0.034 | Imidazoline I1 receptor antagonist | |||
| 0.083 | 0.054 | 0.092 | CC chemokine 5 receptor agonist | 0.092 0.033 CID_5488302 | CID_5488302 | |
| 0.096 | 0.068 | 0.098 | Anabolic | 0.098 0.065 CID_5488302 | CID_5488302 | |
| 0.032 | 0.005 | 0.032 | Sodium/hydrogen exchanger inhibitor | |||
| 0.079 | 0.051 | 0.079 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.081 | 0.054 | 0.128 | Glycine receptor antagonist | 0.128 0.014 CID_5488285 0.128 0.014 CID_5488302 | CID_5488302 | |
| 0.092 | 0.065 | 0.092 | CDK2/cyclin A inhibitor | |||
| 0.093 | 0.068 | 0.289 | Xanthine oxidase inhibitor | 0.289 0.008 CID_5488285 | CID_5488285 | |
| 0.114 | 0.089 | 0.114 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.072 | 0.048 | 0.072 | Benzodiazepine agonist | |||
| 0.064 | 0.041 | 0.064 | I kappa B kinase 2 inhibitor | |||
| 0.168 | 0.145 | 0.541 | Antioxidant | 0.541 0.016 CID_5488285 0.268 0.075 CID_5488302 | CID_5488285 | |
| 0.068 | 0.045 | 0.068 | Potassium channel (ATP-sensitive) blocker | |||
| 0.152 | 0.13 | 0.152 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.088 | 0.066 | 0.088 | Glutamate release inhibitor | 0.083 0.082 CID_5488285 | ||
| 0.087 | 0.066 | 0.087 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.112 | 0.091 | 0.203 | DNA repair enzyme inhibitor | 0.203 0.008 CID_5488285 | CID_5488285 | |
| 0.117 | 0.096 | 0.244 | Lipid peroxidase inhibitor | 0.244 0.028 CID_5488285 | CID_5488285 | |
| 0.05 | 0.029 | 0.05 | Dopamine beta hydroxylase inhibitor | |||
| 0.09 | 0.069 | 0.09 | Toll-Like receptor 3 antagonist | |||
| 0.079 | 0.058 | 0.079 | Platelet growth factor antagonist | |||
| 0.075 | 0.055 | 0.117 | Na+ K+ transporting ATPase inhibitor | 0.117 0.018 CID_5488285 0.096 0.035 CID_5488302 | CID_5488285 | |
| 0.062 | 0.042 | 0.062 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.072 | 0.053 | 0.072 | Janus tyrosine kinase 2 inhibitor | |||
| 0.072 | 0.053 | 0.072 | Protein kinase B beta inhibitor | |||
| 0.084 | 0.067 | 0.137 | NADH dehydrogenase inhibitor | 0.137 0.021 CID_5488285 | CID_5488285 | |
| 0.078 | 0.062 | 0.078 | ALK inhibitor | |||
| 0.105 | 0.09 | 0.107 | Aldehyde dehydrogenase inhibitor | 0.107 0.086 CID_5488285 | CID_5488285 | |
| 0.057 | 0.044 | 0.057 | Dopamine D4 antagonist | |||
| 0.096 | 0.084 | 0.096 | DOPA decarboxylase inhibitor | |||
| 0.131 | 0.119 | 0.131 | TRKC antagonist | |||
| 0.066 | 0.054 | 0.066 | CDK2/cyclin E2 inhibitor | |||
| 0.106 | 0.095 | 0.106 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.055 | 0.044 | 0.055 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.068 | 0.058 | 0.068 | Glutamate decarboxylase inhibitor | |||
| 0.061 | 0.052 | 0.061 | Transcription factor RelA inhibitor | |||
| 0.103 | 0.094 | 0.103 | MAP kinase 12 inhibitor | |||
| 0.035 | 0.026 | 0.035 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.074 | 0.066 | 0.086 | Carbonic anhydrase VI inhibitor | 0.086 0.051 CID_5488302 | CID_5488302 | |
| 0.048 | 0.04 | 0.096 | H+/K+-transporting ATPase inhibitor | 0.096 0.009 CID_5488302 | CID_5488302 | |
| 0.05 | 0.044 | 0.05 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.053 | 0.046 | 0.053 | Aromatase inhibitor | |||
| 0.054 | 0.048 | 0.054 | Protein kinase C iota inhibitor | |||
| 0.08 | 0.075 | 0.08 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.101 | 0.096 | 0.136 | Glutamate receptor antagonist | 0.136 0.061 CID_5488302 | CID_5488302 | |
| 0.082 | 0.078 | 0.082 | Platelet activating factor alpha antagonist | |||
| 0.053 | 0.05 | 0.053 | Pregnane X receptor antagonist | |||
| 0.018 | 0.015 | 0.018 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.013 | 0.01 | 0.013 | Glucocorticoid agonist | |||
| 0.043 | 0.041 | 0.043 | Aldosterone antagonist | |||
| 0.097 | 0.094 | 0.118 | TRPA1 agonist | 0.118 0.061 CID_5488302 | CID_5488302 | |
| 0.068 | 0.066 | 0.155 | Phosphodiesterase VI inhibitor | 0.155 0.006 CID_5488285 0.078 0.044 CID_5488302 | CID_5488285 | |
| 0.077 | 0.076 | 0.077 | mTOR complex 2 inhibitor | |||
| 0.076 | 0.075 | 0.076 | Myeloperoxidase inhibitor | |||
| 0.095 | 0.095 | 0.208 | Alkylator | 0.208 0.024 CID_5488285 | CID_5488285 | |
| 0.133 | 0.134 | 0.281 | ATPase inhibitor | 0.281 0.008 CID_5488285 | CID_5488285 | |
| 0.08 | 0.082 | 0.108 | Thioredoxin inhibitor | 0.108 0.04 CID_5488285 | CID_5488285 | |
| 0.048 | 0.053 | 0.084 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.084 0.019 CID_5488285 | CID_5488285 | |
| 0.12 | 0.126 | 0.128 | Adenylate cyclase stimulant | 0.128 0.107 CID_5488302 | CID_5488302 | |
| 0.085 | 0.092 | 0.217 | Phosphodiesterase 6D inhibitor | 0.217 0.004 CID_5488285 0.112 0.034 CID_5488302 | CID_5488285 | |
| 0.086 | 0.096 | 0.125 | Cystathionine beta-synthase inhibitor | 0.125 0.054 CID_5488285 | CID_5488285 | |
| 0.093 | 0.104 | 0.136 | Microtubule formation inhibitor | 0.136 0.046 CID_5488285 | CID_5488285 | |
| 0.08 | 0.093 | 0.242 | Mediator release inhibitor | 0.242 0.01 CID_5488285 | CID_5488285 | |
| 0.077 | 0.093 | 0.242 | Topoisomerase I inhibitor | 0.242 0.018 CID_5488285 | CID_5488285 | |
| 0.074 | 0.092 | 0.101 | Breast cancer-resistant protein inhibitor | 0.101 0.054 CID_5488302 | CID_5488302 | |
| 0.128 | 0.155 | 0.354 | Non-steroidal antiinflammatory agent | 0.354 0.019 CID_5488285 | CID_5488285 | |
| 0.089 | 0.119 | 0.18 | Alpha-N-acetylglucosaminidase inhibitor | 0.18 0.041 CID_5488285 | CID_5488285 | |
| 0.026 | 0.062 | 0.033 | Protein kinase C beta I inhibitor | 0.033 0.026 CID_5488285 | CID_5488285 | |
| 0.115 | 0.151 | 0.157 | CC chemokine 6 receptor antagonist | 0.157 0.015 CID_5488285 | CID_5488285 | |
| 0.105 | 0.152 | 0.461 | Hemostatic | 0.461 0.005 CID_5488285 0.442 0.005 CID_5488302 | CID_5488285 | |
| 0.061 | 0.108 | 0.197 | Monophenol monooxygenase inhibitor | 0.197 0.034 CID_5488285 | CID_5488285 | |
| 0.024 | 0.072 | 0.043 | Factor XIa inhibitor | 0.043 0.025 CID_5488302 | CID_5488302 | |
| 0.069 | 0.127 | 0.236 | Topoisomerase II inhibitor | 0.236 0.027 CID_5488285 | CID_5488285 | |
| 0.019 | 0.083 | 0.048 | Factor XI inhibitor | 0.048 0.011 CID_5488302 | CID_5488302 | |
| 0.08 | 0.145 | 0.146 | Acetylcholine release stimulant | 0.109 0.067 CID_5488285 0.146 0.019 CID_5488302 | CID_5488302 | |
| 0.083 | 0.15 | 0.143 | Alkaline phosphatase inhibitor | 0.12 0.086 CID_5488285 0.143 0.064 CID_5488302 | CID_5488302 | |
| 0.094 | 0.163 | 0.128 | Mannose-6-phosphate isomerase inhibitor | 0.128 0.088 CID_5488285 | CID_5488285 | |
| 0.12 | 0.191 | 0.15 | Heat shock protein 70 antagonist | 0.15 0.045 CID_5488285 | CID_5488285 | |
| 0.086 | 0.162 | 0.12 | Antibacterial (Helicobacter pylori) | 0.12 0.082 CID_5488302 | CID_5488302 | |
| 0.032 | 0.11 | 0.119 | Phosphofructokinase-1 inhibitor | 0.119 0.025 CID_5488285 | CID_5488285 | |
| 0.01 | 0.092 | 0.019 | Antibiotic Anthracycline-like | 0.019 0.013 CID_5488285 | CID_5488285 | |
| 0.142 | 0.233 | 0.297 | Hypoxia-inducible factor 1 alpha inhibitor | 0.297 0.067 CID_5488285 | CID_5488285 | |
| 0.028 | 0.121 | 0.044 | Glucose-6-phosphate isomerase inhibitor | 0.044 0.042 CID_5488285 | CID_5488285 | |
| 0.114 | 0.212 | 0.449 | Tumour necrosis factor alpha release inhibitor | 0.449 0.02 CID_5488285 0.179 0.127 CID_5488302 | CID_5488285 | |
| 0.044 | 0.142 | 0.141 | CDC25A inhibitor | 0.141 0.014 CID_5488302 | CID_5488302 | |
| 0.146 | 0.245 | 0.498 | Angiogenesis inhibitor | 0.34 0.075 CID_5488285 0.498 0.03 CID_5488302 | CID_5488302 | |
| 0.071 | 0.171 | 0.254 | Cyclooxygenase 3 inhibitor | 0.254 0.008 CID_5488285 | CID_5488285 | |
| 0.094 | 0.194 | 0.342 | Nitric oxide antagonist | 0.342 0.033 CID_5488285 | CID_5488285 | |
| 0.053 | 0.158 | 0.174 | Gastric antisecretory | 0.174 0.018 CID_5488302 | CID_5488302 | |
| 0.04 | 0.15 | 0.121 | MAP kinase kinase 10 inhibitor | 0.121 0.014 CID_5488302 | CID_5488302 | |
| 0.094 | 0.205 | 0.184 | Melanin inhibitor | 0.184 0.049 CID_5488285 | CID_5488285 | |
| 0.064 | 0.177 | 0.137 | Interleukin 12 antagonist | 0.137 0.017 CID_5488285 | CID_5488285 | |
| 0.008 | 0.129 | 0.043 | Dopamine D1 agonist | 0.037 0.006 CID_5488285 0.043 0.005 CID_5488302 | CID_5488302 | |
| 0.075 | 0.2 | 0.204 | Protein kinase stimulant | 0.204 0.04 CID_5488285 | CID_5488285 | |
| 0.024 | 0.153 | 0.16 | Antineoplastic antibiotic | 0.16 0.029 CID_5488285 | CID_5488285 | |
| 0.027 | 0.166 | 0.093 | Heparanase inhibitor | 0.093 0.004 CID_5488285 0.054 0.034 CID_5488302 | CID_5488285 | |
| 0.042 | 0.185 | 0.075 | Inducible nitric-oxide synthase inhibitor | 0.075 0.071 CID_5488302 | CID_5488302 | |
| 0.091 | 0.238 | 0.367 | Antiamyloidogenic | 0.367 0.035 CID_5488285 | CID_5488285 | |
| 0.039 | 0.189 | 0.087 | Alcohol dehydrogenase inhibitor | 0.087 0.069 CID_5488285 | CID_5488285 | |
| 0.084 | 0.236 | 0.236 | DNA methylase inhibitor | 0.236 0.056 CID_5488285 | CID_5488285 | |
| 0.131 | 0.284 | 0.415 | Immunosuppressant | 0.415 0.057 CID_5488285 | CID_5488285 | |
| 0.052 | 0.207 | 0.287 | AMP-activated protein kinase stimulant | 0.287 0.005 CID_5488285 | CID_5488285 | |
| 0.051 | 0.21 | 0.326 | Amylase inhibitor | 0.326 0.015 CID_5488285 | CID_5488285 | |
| 0.126 | 0.289 | 0.348 | Vasodilator, coronary | 0.348 0.056 CID_5488285 | CID_5488285 | |
| 0.088 | 0.253 | 0.506 | Free radical scavenger | 0.506 0.016 CID_5488285 | CID_5488285 | |
| 0.098 | 0.264 | 0.141 | Phospholipase C inhibitor | 0.141 0.125 CID_5488302 | CID_5488302 | |
| 0.02 | 0.187 | 0.345 | Selectin antagonist | 0.345 0.004 CID_5488285 0.192 0.012 CID_5488302 | CID_5488285 | |
| 0.011 | 0.181 | 0.064 | Carbonic anhydrase VB inhibitor | 0.064 0.032 CID_5488302 | CID_5488302 | |
| 0.016 | 0.193 | 0.731 | Cholecystokinin B agonist | 0.731 0.001 CID_5488302 | CID_5488302 | |
| 0.008 | 0.188 | 0.041 | Sodium/glucose cotransporter inhibitor | 0.041 0.007 CID_5488285 | CID_5488285 | |
| 0.073 | 0.255 | 0.203 | DNA methyltransferase I inhibitor | 0.203 0.068 CID_5488285 | CID_5488285 | |
| 0.015 | 0.199 | 0.032 | Toll-Like receptor 4 agonist | 0.031 0.01 CID_5488285 0.032 0.009 CID_5488302 | CID_5488302 | |
| 0.027 | 0.212 | 0.142 | Topoisomerase II alpha inhibitor | 0.142 0.025 CID_5488285 | CID_5488285 | |
| 0.008 | 0.194 | 0.056 | Dopamine D2 agonist | 0.056 0.023 CID_5488302 | CID_5488302 | |
| 0.022 | 0.211 | 0.1 | Carbonic anhydrase VA inhibitor | 0.1 0.025 CID_5488302 | CID_5488302 | |
| 0.074 | 0.263 | 0.437 | Platelet adhesion inhibitor | 0.437 0.009 CID_5488285 0.42 0.01 CID_5488302 | CID_5488285 | |
| 0.025 | 0.215 | 0.142 | Carbonic anhydrase XIII inhibitor | 0.142 0.023 CID_5488302 | CID_5488302 | |
| 0.133 | 0.328 | 0.589 | Antibacterial | 0.589 0.021 CID_5488285 0.29 0.143 CID_5488302 | CID_5488285 | |
| 0.006 | 0.202 | 0.041 | Sodium/glucose cotransporter 2 inhibitor | 0.041 0.008 CID_5488285 | CID_5488285 | |
| 0.046 | 0.254 | 0.19 | Beta amyloid protein antagonist | 0.19 0.02 CID_5488285 | CID_5488285 | |
| 0.018 | 0.229 | 0.139 | Carbonic anhydrase V inhibitor | 0.139 0.017 CID_5488302 | CID_5488302 | |
| 0.101 | 0.332 | 0.45 | Cholesterol antagonist | 0.45 0.041 CID_5488285 0.272 0.11 CID_5488302 | CID_5488285 | |
| 0.005 | 0.238 | 0.772 | Cholecystokinin A agonist | 0.772 0.001 CID_5488302 | CID_5488302 | |
| 0.008 | 0.244 | 0.042 | Phosphorylase inhibitor | 0.042 0.035 CID_5488285 | CID_5488285 | |
| 0.039 | 0.282 | 0.307 | Thrombolytic | 0.307 0.023 CID_5488285 0.201 0.051 CID_5488302 | CID_5488285 | |
| 0.064 | 0.31 | 0.254 | Spasmolytic | 0.254 0.09 CID_5488285 | CID_5488285 | |
| 0.004 | 0.255 | 0.783 | Cholecystokinin agonist | 0.783 0.002 CID_5488302 | CID_5488302 | |
| 0.061 | 0.312 | 0.227 | Interleukin agonist | 0.227 0.097 CID_5488285 | CID_5488285 | |
| 0.004 | 0.256 | 0.419 | Cholecystokinin A antagonist | 0.419 0.003 CID_5488302 | CID_5488302 | |
| 0.02 | 0.271 | 0.058 | DNA gyrase inhibitor | 0.058 0.052 CID_5488285 | CID_5488285 | |
| 0.011 | 0.264 | 0.048 | Mannosidase inhibitor | 0.048 0.027 CID_5488285 | CID_5488285 | |
| 0.015 | 0.269 | 0.055 | Alpha-mannosidase inhibitor | 0.055 0.034 CID_5488285 | CID_5488285 | |
| 0.025 | 0.293 | 0.187 | Expectorant | 0.187 0.023 CID_5488285 | CID_5488285 | |
| 0.05 | 0.319 | 0.202 | Cell wall synthesis inhibitor | 0.202 0.029 CID_5488285 0.169 0.048 CID_5488302 | CID_5488285 | |
| 0.036 | 0.305 | 0.226 | Multidrug resistance-associated protein 1 inhibitor | 0.226 0.006 CID_5488302 | CID_5488302 | |
| 0.005 | 0.279 | 0.362 | Cholecystokinin antagonist | 0.362 0.004 CID_5488302 | CID_5488302 | |
| 0.009 | 0.288 | 0.057 | Leukocyte elastase inhibitor | 0.057 0.02 CID_5488302 | CID_5488302 | |
| 0.054 | 0.337 | 0.389 | Immunostimulant | 0.389 0.053 CID_5488285 | CID_5488285 | |
| 0.041 | 0.333 | 0.143 | Toll-Like receptor 4 antagonist | 0.143 0.025 CID_5488285 | CID_5488285 | |
| 0.012 | 0.305 | 0.048 | Purinergic P2Y2 antagonist | 0.048 0.011 CID_5488302 | CID_5488302 | |
| 0.103 | 0.414 | 0.395 | Apoptosis antagonist | 0.395 0.04 CID_5488285 | CID_5488285 | |
| 0.059 | 0.37 | 0.366 | Vasodilator | 0.366 0.029 CID_5488285 | CID_5488285 | |
| 0.04 | 0.354 | 0.61 | Angiogenesis stimulant | 0.61 0.006 CID_5488285 0.372 0.027 CID_5488302 | CID_5488285 | |
| 0.007 | 0.333 | 0.071 | NMDA 2D receptor antagonist | 0.071 0.005 CID_5488302 | CID_5488302 | |
| 0.028 | 0.355 | 0.126 | Uric acid excretion stimulant | 0.126 0.034 CID_5488285 | CID_5488285 | |
| 0.022 | 0.357 | 0.124 | Histone deacetylase stimulant | 0.124 0.016 CID_5488285 | CID_5488285 | |
| 0.022 | 0.357 | 0.124 | Histone deacetylase SIRT1 stimulant | 0.124 0.016 CID_5488285 | CID_5488285 | |
| 0.023 | 0.374 | 0.114 | ATPase (Vacuolar H+) inhibitor | 0.114 0.024 CID_5488285 | CID_5488285 | |
| 0.071 | 0.434 | 0.493 | Antithrombotic | 0.493 0.03 CID_5488285 0.245 0.13 CID_5488302 | CID_5488285 | |
| 0.041 | 0.409 | 0.264 | Platelet antagonist | 0.264 0.067 CID_5488285 | CID_5488285 | |
| 0.054 | 0.425 | 0.294 | Alpha-glucosidase inhibitor | 0.294 0.163 CID_5488285 | CID_5488285 | |
| 0.1 | 0.481 | 0.381 | Interleukin 2 agonist | 0.381 0.033 CID_5488285 | CID_5488285 | |
| 0.008 | 0.391 | 0.132 | HIV-1 integrase (Strand Transfer) inhibitor | 0.132 0.014 CID_5488302 | CID_5488302 | |
| 0.004 | 0.388 | 0.317 | Cholecystokinin B antagonist | 0.317 0.004 CID_5488302 | CID_5488302 | |
| 0.01 | 0.399 | 0.081 | Elastase inhibitor | 0.081 0.016 CID_5488302 | CID_5488302 | |
| 0.026 | 0.421 | 0.183 | Diuretic | 0.183 0.052 CID_5488302 | CID_5488302 | |
| 0.031 | 0.432 | 0.101 | DNA polymerase I inhibitor | 0.101 0.085 CID_5488285 | CID_5488285 | |
| 0.005 | 0.412 | 0.087 | Estrogen agonist | 0.087 0.021 CID_5488302 | CID_5488302 | |
| 0.008 | 0.427 | 0.14 | HIV-1 integrase (3'-Processing) inhibitor | 0.14 0.015 CID_5488302 | CID_5488302 | |
| 0.014 | 0.454 | 0.068 | HIV-1 integrase inhibitor | 0.068 0.051 CID_5488302 | CID_5488302 | |
| 0.028 | 0.47 | 0.266 | Dual specificity phosphatase inhibitor | 0.266 0.034 CID_5488302 | CID_5488302 | |
| 0.023 | 0.5 | 0.272 | Dual specificity phosphatase 3 inhibitor | 0.272 0.034 CID_5488302 | CID_5488302 | |
| 0.084 | 0.568 | 0.361 | Peptidyltransferase inhibitor | 0.361 0.01 CID_5488285 | CID_5488285 | |
| 0.005 | 0.504 | 0.255 | NMDA 2B receptor antagonist | 0.255 0.005 CID_5488302 | CID_5488302 | |
| 0.025 | 0.532 | 0.112 | Nav1.4 sodium channel blocker | 0.112 0.06 CID_5488302 | CID_5488302 | |
| 0.005 | 0.518 | 0.031 | Protein 30S ribosomal subunit inhibitor | 0.031 0.012 CID_5488285 | CID_5488285 | |
| 0.013 | 0.559 | 0.074 | Glucose-6-phosphate translocase inhibitor | 0.074 0.014 CID_5488285 | CID_5488285 | |
| 0.02 | 0.573 | 0.064 | Adenine nucleotide translocase inhibitor | 0.056 0.037 CID_5488285 0.064 0.022 CID_5488302 | CID_5488302 | |
| 0.006 | 0.561 | 0.099 | Protein-tyrosine phosphatase 1B inhibitor | 0.099 0.079 CID_5488302 | CID_5488302 | |
| 0.036 | 0.597 | 0.353 | Hepatoprotectant | 0.353 0.018 CID_5488285 | CID_5488285 | |
| 0.009 | 0.613 | 0.241 | Protein-tyrosine phosphatase inhibitor | 0.241 0.033 CID_5488302 | CID_5488302 | |
| 0.05 | 0.658 | 0.242 | Caspase 3 stimulant | 0.242 0.119 CID_5488285 | CID_5488285 | |
| 0.014 | 0.648 | 0.098 | Factor IXa inhibitor | 0.084 0.014 CID_5488285 0.098 0.01 CID_5488302 | CID_5488302 | |
| 0.012 | 0.655 | 0.427 | Anticoagulant | 0.178 0.062 CID_5488285 0.427 0.014 CID_5488302 | CID_5488302 | |
| 0.002 | 0.654 | 0.106 | Estrone sulfatase inhibitor | 0.106 0.004 CID_5488302 | CID_5488302 | |
| 0.026 | 0.682 | 0.118 | Transcription factor NF kappa B stimulant | 0.118 0.026 CID_5488285 | CID_5488285 | |
| 0.008 | 0.689 | 0.085 | Protein 50S ribosomal subunit inhibitor | 0.085 0.018 CID_5488285 | CID_5488285 | |
| 0.003 | 0.765 | 0.034 | 1,3-Beta-glucan synthase inhibitor | 0.034 0.008 CID_5488302 | CID_5488302 | |
| 0.005 | 0.783 | 0.061 | Neuraminidase (influenza) inhibitor | 0.061 0.051 CID_5488285 | CID_5488285 | |
| 0.01 | 0.804 | 0.248 | Insulin secretagoues | 0.248 0.02 CID_5488285 | CID_5488285 | |
| 0.007 | 0.812 | 0.065 | Antibiotic Aminoglycoside-like | 0.065 0.007 CID_5488285 | CID_5488285 | |
| 0.011 | 0.818 | 0.23 | Antiobesity | 0.23 0.176 CID_5488302 | CID_5488302 | |
| 0.014 | 0.859 | 0.361 | Immunomodulator | 0.361 0.056 CID_5488285 | CID_5488285 | |
| 0.005 | 0.86 | 0.083 | Thrombin inhibitor | 0.083 0.039 CID_5488302 | CID_5488302 | |
| 0.005 | 0.882 | 0.084 | Cell adhesion molecule inhibitor | 0.084 0.048 CID_5488285 | CID_5488285 | |
| 0.009 | 0.903 | 0.558 | Hypoglycemic | 0.558 0.011 CID_5488285 | CID_5488285 | |
| 0.005 | 0.906 | 0.17 | Hypolipemic | 0.17 0.118 CID_5488285 | CID_5488285 | |
| 0.006 | 0.914 | 0.688 | Cyclophilin D inhibitor | 0.688 0.015 CID_5488285 | CID_5488285 | |
| 0.005 | 0.918 | 0.166 | Cell adhesion inhibitor | 0.166 0.037 CID_5488285 | CID_5488285 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |